Alexion to acquire fellow US drugmaker Synageva in $8.4bn deal, handing key roles to Wachtell, Sullivan and Ropes
May 07, 2015 at 11:01 AM
1 minute read
The original version of this story was published on Legalweek
Wachtell Lipton Rosen & Katz, Sullivan & Cromwell and Ropes & Gray have grabbed lead roles on US pharmaceutical company Alexion’s $8.4bn (£5.5bn) purchase of fellow US drugmaker Synageva.
The deal is the latest in a string of high-profile pharma deals this year and will see Alexion pay more than twice the market value for Synageva.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
